Optimizing the treatment of acute cardiac rejection: combination therapy of ECMO, plasmapheresis and immunoglobulin, a promising approach for humoral and cellular cardiac recovery
Event:
Heart Failure 2024
Topic:
Clinical
Session:
Challenges following heart transplantation
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
